A Study of Safety, Tolerability and Immunogenicity of HPV-L2 Vaccine in Healthy Adult Male and Female Subjects
Status:
Completed
Trial end date:
2020-05-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, and the immunological
effects of adeno-associated virus-like particle human papillomavirus (AAVLP-HPV) vaccine in
healthy adults.